Tirzepatide leads to significantly greater weight loss than semaglutide in overweight or obese adults, with no significant difference in gastrointestinal adverse effects.
Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults
- Post author:
- Post published:July 10, 2024
- Post category:uncategorized